ARTICLE | Distillery Therapeutics
Therapeutics: MAP kinase 1 (MAPK1; ERK-2); BRAF
July 28, 2016 7:00 AM UTC
In vitro, cell culture and mouse studies identified a MAPK1 inhibitor that could help treat BRAF-mutant melanoma. Chemical synthesis and in vitro testing of pyrazolopyridinyl urea analogs identified a...